The global analytical standards market size was estimated at around USD 1.37 billion in 2023 and it is projected to hit around USD 2.59 billion by 2033, growing at a CAGR of 6.58% from 2024 to 2033. The growth of the market is linked to the growing demand for testing within the pharmaceuticals, environmental monitoring, and food and beverage industries.
The analytical standards market plays a pivotal role in ensuring the accuracy and reliability of analytical measurements across various industries. These standards serve as reference materials, allowing laboratories and researchers to calibrate and validate their instruments, ensuring the consistency and traceability of analytical results. This overview delves into the key aspects of the analytical standards market, highlighting its significance, major players, and emerging trends.
The growth of the analytical standards market is propelled by several key factors. Firstly, the escalating demand for precise and reliable analytical measurements across diverse industries, including pharmaceuticals, environmental monitoring, and clinical diagnostics, contributes significantly to market expansion. Stringent regulatory standards further drive the need for high-quality analytical standards, as compliance with these regulations is paramount for ensuring product safety and efficacy. The continuous advancement of analytical techniques, such as chromatography and spectroscopy, fuels market growth by necessitating the development of new and specialized analytical standards. Established market players like Merck KGaA, Agilent Technologies, Inc., Sigma-Aldrich (now part of MilliporeSigma), and Restek Corporation continue to innovate and collaborate, maintaining their dominance in the market. The emergence of trends like customized solutions to address specific industry challenges and the integration of digital technologies for enhanced data management and traceability further contribute to the dynamic growth of the analytical standards market.
In 2023, the spectroscopy segment emerged as the market leader, capturing the largest revenue share at 45%. This segment is poised to experience the swiftest Compound Annual Growth Rate (CAGR) throughout the forecast period. The surge in adoption of advanced spectroscopic techniques across pharmaceuticals, environmental testing, and food and beverage industries propels this growth. Particularly in pharmaceutical development, the demand for precise analysis is met through spectroscopy, playing a pivotal role in drug formulation and quality control. Notably, the pharmaceutical sector extensively employs high-performance liquid chromatography (HPLC) coupled with mass spectrometry for drug compound analysis, intensifying the need for certified reference materials (CRMs) to uphold analytical result accuracy and reliability.
Concurrently, the physical property testing segment anticipates substantial growth, driven by industries aspiring for higher product quality. Robust quality control and assurance measures, facilitated by physical property testing, are deemed essential to ensure materials and products adhere to specified standards, thus enabling companies to uphold consistency and reliability.
In 2023, the organic analytical standards segment emerged as the market leader, securing the largest revenue share at 57%. These standards are indispensable for ensuring the precision and dependability of analytical measurements across diverse industries, including pharmaceuticals, environmental testing, and the food and beverage sector. The growing complexity of organic compounds used in these industries serves as a significant driver for the heightened use of organic analytical standards. Notably, in the pharmaceutical sector, the development of new drug compounds necessitates meticulous analysis, thereby amplifying the demand for organic analytical standards to facilitate calibration and validation processes.
Furthermore, the escalating emphasis on environmental protection has spurred the requirement for organic analytical standards in analyzing pollutants and contaminants present in air, water, and soil. This trend is anticipated to persist, fostering sustained demand for organic analytical standards in the foreseeable future. Conversely, the inorganic analytical standards segment is poised to experience a stable Compound Annual Growth Rate (CAGR) throughout the forecast period.
In 2023, the pharmaceutical and life science segment took the lead in the market, securing the largest revenue share at 23%. Analytical standards play a pivotal role in the realm of pharmaceutical and life science research and development, ensuring the precision and reliability of measurements critical for drug development and testing. For instance, in the creation of a new drug, analytical standards are instrumental in gauging the purity and potency of the active pharmaceutical ingredient (API).
Concurrently, the food and beverage analysis segment anticipates a lucrative Compound Annual Growth Rate (CAGR) throughout the forecast period. The complexity of global food supply chains and the imperative for rigorous quality control have fueled a notable upswing in the demand for analytical standards within the food and beverage industry. Precise measurement and verification of ingredients, contaminants, and nutritional content are crucial to ensuring compliance with regulatory standards and meeting consumer expectations for safety and transparency, factors expected to drive increased demand in the years to come
In 2023, the bioanalytical testing segment emerged as the market leader, capturing the largest revenue share at 34%. This segment holds immense importance in drug development and pharmacokinetic studies, heavily relying on analytical standards to achieve accurate and reliable results. A key driver for utilizing analytical standards in bioanalytical testing is the imperative for consistent and reproducible measurements, ensuring the safety and efficacy of drugs. For instance, in pharmacokinetic studies, analytical standards play a vital role in calibrating instruments and validating methods for quantifying drugs and their metabolites in biological samples.
Concurrently, the stability testing segment is anticipated to exhibit the fastest Compound Annual Growth Rate (CAGR) over the forecast period. This growth is fueled by regulatory requirements and the necessity to uphold product quality. In stability testing, analytical standards are employed to monitor drug degradation over time, involving the exposure of samples to various stress conditions and subsequent analysis using chromatography or spectroscopy. The rapid expansion of drug development and increasing regulatory demands are expected to drive significant growth in the stability testing segment.
In 2023, North America emerged as the dominant force in the market, securing a substantial revenue share of 44%. This leadership is attributed to various factors, including stringent regulatory requirements, technological advancements, and the presence of key market players. Regulatory bodies such as the FDA and EPA mandate the use of analytical standards to ensure the quality and safety of pharmaceuticals, food, and environmental samples. The region is also witnessing a surge in demand for more sophisticated analytical standards, driven by continuous technological advancements, especially in the development of high-performance analytical instruments.
Meanwhile, the Asia Pacific region is poised to experience the fastest Compound Annual Growth Rate (CAGR) during the forecast period. This growth is propelled by factors such as increasing industrialization, the burgeoning pharmaceutical and biotechnology industries, and a heightened focus on food safety and environmental monitoring. Significant opportunities for market expansion are evident, particularly in economically dynamic countries like China, India, and Japan, which are witnessing rapid economic growth and technological advancements.
By Category
By Technique
By Application
By Methodology
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Analytical Standards Market
5.1. COVID-19 Landscape: Analytical Standards Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Analytical Standards Market, By Category
8.1. Analytical Standards Market, by Category, 2024-2033
8.1.1. Organic Analytical Standards
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. In-organic Analytical Standards
8.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Analytical Standards Market, By Technique
9.1. Analytical Standards Market, by Technique, 2024-2033
9.1.1. Spectroscopy
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Chromatography
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Titrimetry
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Physical Property Testing
9.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Analytical Standards Market, By Application
10.1. Analytical Standards Market, by Application, 2024-2033
10.1.1. Pharmaceutical and Life Science Analysis
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Environmental Analysis
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Food and Beverage Analysis
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Forensic Standards
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Petrochemical Analysis
10.1.5.1. Market Revenue and Forecast (2021-2033)
10.1.6. Veterinary Drug Analysis
10.1.6.1. Market Revenue and Forecast (2021-2033)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Analytical Standards Market, By Methodology
11.1. Analytical Standards Market, by Methodology, 2024-2033
11.1.1. Bioanalytical Testing
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Stability Testing
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Raw Material Testing
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Dissolution testing
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Analytical Standards Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Category (2021-2033)
12.1.2. Market Revenue and Forecast, by Technique (2021-2033)
12.1.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Category (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Technique (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Category (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Technique (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Category (2021-2033)
12.2.2. Market Revenue and Forecast, by Technique (2021-2033)
12.2.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Category (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Technique (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Category (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Technique (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Category (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Technique (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Category (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Technique (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Category (2021-2033)
12.3.2. Market Revenue and Forecast, by Technique (2021-2033)
12.3.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Category (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Technique (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Category (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Technique (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Category (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Technique (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Category (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Technique (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Category (2021-2033)
12.4.2. Market Revenue and Forecast, by Technique (2021-2033)
12.4.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Category (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Technique (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Category (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Technique (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Category (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Technique (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Category (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Technique (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Category (2021-2033)
12.5.2. Market Revenue and Forecast, by Technique (2021-2033)
12.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Category (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Technique (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Forecast, by Methodology (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Category (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Technique (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Forecast, by Methodology (2021-2033)
Chapter 13. Company Profiles
13.1. Merck KGaA
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Waters Corporation
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Agilent Technologies, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Shimadzu Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. PerkinElmer Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. LGC Limited
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Restek Corporation.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. AccuStandard
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Cayman Chemical
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. RICCA Chemical Company
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms